Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.15 USD | +11.23% | +20.93% | -59.61% |
Apr. 18 | Sector Update: Health Care Stocks Ease in Afternoon Trading | MT |
Apr. 18 | Moleculin Biotech Secures Orphan Drug Label For Annamycin in EU | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.61% | 10.31M | |
-2.73% | 103B | |
+1.42% | 95.28B | |
+1.46% | 22.15B | |
-15.88% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.92% | 16.05B | |
+5.05% | 13.68B | |
+33.49% | 12.17B |
- Stock Market
- Equities
- MBRX Stock
- News Moleculin Biotech, Inc.
- Moleculin Biotech to Effect 1-For-15 Reverse Stock Split to Regain Compliance